DBV Technologies S.A. (NASDAQ:DBVT)

CAPS Rating: 5 out of 5

Caps

How do you think DBVT will perform against the market?

Add Stock to CAPS Watchlist

All Players

11 Outperform
0 Underperform
 

All-Star Players

4 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top DBVT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

DBVT VS S&P 500 (SPY)

DBVT Summary

Recent Community Commentary

Read the most recent pitches from players about DBVT.

Recs

0
Member Avatar MarkBiotech (30.95) Submitted: 3/7/2018 3:41:31 PM : Outperform Start Price: $22.21 DBVT Score: +3.23

although viaskin didn't reach its PE of efficacy, the responder rates were still significant over placebo. There were no concerning TEAE's.. Viaskin's strong safety profile is what will put patients preference over AIMT's Ar101. AR101 experienced a 12.4% discontinuation rate due to TEAE's meanwhile viaskin TEAE DR, was 1.1%. At the EOD, the patients are what matters the most. a risk of anaphylaxis is not something a parent will gamble with.. safety will always be the top priority when it comes to the parents choice for their kids. For that reason.. i'm going to go with viaskin as the SOC for peanut allergy resistance over AR101. Viaskin is also applicable in many other allergies including milk, nuts, egg.. Viaskin expansion of indications could easily put sales over 1b or a price of 100 PPS. PT-100.

Recs

0
Member Avatar stationfool (71.79) Submitted: 6/23/2015 1:09:32 PM : Outperform Start Price: $33.72 DBVT Score: -70.51

Peanut Allergy Drug

Leaderboard

Find the members with the highest scoring picks in DBVT.

Score Leader

sln

sln (67.48) Score: +87.12

The Score Leader is the player with the highest score across all their picks in DBVT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
gunda7907 30.06 2/28/2018 Outperform 5Y $21.58 +13.93% +6.74% +7.19 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MarkBiotech 30.95 3/7/2018 Outperform 5Y $22.21 +10.67% +7.44% +3.23 1 Comment
sublimeinvestor 30.17 3/20/2018 Outperform 5Y $22.51 +9.20% +7.77% +1.43 0 Comment
Plasmidologist 31.26 3/20/2018 Outperform 5Y $22.51 +9.20% +7.77% +1.43 0 Comment
Momentum21 92.02 2/22/2018 Outperform 5Y $24.08 +2.08% +7.01% -4.93 0 Comment
portefeuille2 99.26 5/18/2018 Outperform 5Y $24.77 -0.77% +7.58% -8.35 0 Comment
HealthcareGuy 96.08 3/19/2015 Outperform 5Y $22.33 +10.08% +39.37% -29.29 0 Comment
portefeuille 98.48 5/26/2015 Outperform 5Y $24.91 -1.32% +37.47% -38.80 0 Comment
jfkiley 73.51 5/13/2016 Outperform 5Y $28.77 -14.56% +42.58% -57.14 0 Comment
stationfool 71.79 10/21/2015 Outperform 5Y $33.72 -27.11% +43.41% -70.51 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DBVT.

Featured Broker Partners


Advertisement